New protein test aims to outsmart lung cancer treatment
NCT ID NCT07250477
Summary
This study is testing if using a special protein test to guide treatment choices helps people with advanced lung cancer live longer without their cancer getting worse, compared to standard treatment selection. It will involve 56 adults with newly diagnosed, advanced non-small cell lung cancer who have not yet started treatment. Participants will be randomly assigned to have their treatment chosen either by the new protein-based method or by the current standard approach.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of California Davis Comprehensive Cancer Center
RECRUITINGSacramento, California, 95817, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.